Shares of Pfizer (PFE) are falling after the company issued 2024 profit and revenue guidance that fell short of Wall Street expectations, as a continued decline in demand for COVID-related products continues to weigh on the drugmaker’s performance. The company also raised its cost-cutting target by $500 million to $4 billion.
Yahoo Finance Health Reporter Anjalee Khemlani joins the the Live show to break down the latest developments for Pfizer and what it could mean going forward.
For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Ακολουθήστε το 
στο Google News και μάθετε πρώτοι όλες τις ειδήσεις
στο Google News και μάθετε πρώτοι όλες τις ειδήσειςΔείτε όλες τις τελευταίες Ειδήσεις από την Ελλάδα και τον Κόσμο, στο
